Medscape

ICE-CHIP: Intracardiac echo and TEE comparable at predicting thromboembolic risk at cardioversion

TEE is commonly used to detect or rule out potentially embolic intra-atrial thrombus or to spontaneous echo contrast (SEC), a sign that suggests impending thrombus, in patients with atrial ...
Medscape

Need for TEE Before AF Ablation Questioned if DOACs on Board: Large Cohort Study

There's no need to double up on echo modalities before and during ablation for atrial fibrillation (AF) as long as the patient has been on uninterrupted therapy with a direct oral anticoagulant (DOAC) ...
TCTMD

Ceiling-Suspended Shields Decrease Radiation Risk for TEE Operators During Structural Heart Procedures

During structural heart procedures, transesophageal echocardiography (TEE) operators are exposed to a dose of radiation that is comparable to that of the primary operator, but the installation of a ...
TCTMD

Miniaturized TEE Probes Safe, Feasible for LAAO Guidance

Miniaturized transesophageal echocardiography (TEE) probes designed for pediatric use appear to be a viable option for guiding left atrial appendage occlusion (LAAO) in patients with atrial ...
Business Insider

Visura Technologies Presents TEECAD Real-World Clinical Data at ASE 2023

First ever clinical data on an innovation specifically designed to advance the TEE procedure will be presented at global echocardiography meeting MINNEAPOLIS, June 20, 2023 /PRNewswire/ -- Visura ...
Nature

Previously published drug interaction models predict loss of response for transoesophageal echocardiography sedation well but not response to oesophageal instrumentation

Response surface models (RSMs) were used to predict effects of multiple drugs interactions. Our study was aimed to validate accuracy of the previous published volunteer models during transoesophageal ...
Business Wire

GE Healthcare Enhances Workflow in Echo Lab, OR and Cath Lab with Vivid E9 Cardiovascular Ultrasound, Now Including 4D TEE Transducer

WAUWATOSA, Wis.--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced the FDA clearance and availability of the latest version of its Vivid E9™ cardiovascular ...